Zobrazeno 1 - 10 of 50 pro vyhledávání: '"Elodie Belnoue"'
2
Akademický článek
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
Autor: Krishna Das, Elodie Belnoue, Matteo Rossi, Tamara Hofer, Sarah Danklmaier, Tobias Nolden, Liesa-Marie Schreiber, Katharina Angerer, Janine Kimpel, Sandra Hoegler, Bart Spiesschaert, Lukas Kenner, Dorothee von Laer, Knut Elbers, Madiha Derouazi, Guido Wollmann
Publikováno v: Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Successful cancer immune therapy correlates with a T cell-inflamed tumour microenvironment. Authors show here that co-administration of a self-adjuvanting protein vaccine and an antigen-expressing oncolytic virus in an optimised regimen strongly enha
Externí odkaz: https://doaj.org/article/6a4885a11bbe41c6aef5c595a4d1525a
Zobrazit plný text záznamu
3
Akademický článek
STING Agonist Combined to a Protein-Based Cancer Vaccine Potentiates Peripheral and Intra-Tumoral T Cell Immunity
Autor: Matteo Rossi, Susanna Carboni, Wilma Di Berardino-Besson, Erika Riva, Marie-Laure Santiago-Raber, Elodie Belnoue, Madiha Derouazi
Publikováno v: Frontiers in Immunology, Vol 12 (2021)
Combining different immunotherapy approaches is currently building the future of immunotherapy, with the view to maximize anti-tumoral efficacy for larger patient population. The KISIMA™ platform allows the development of protein-based cancer vacci
Externí odkaz: https://doaj.org/article/4d671a46c61647fc87fcf3eddf89bcf8
Zobrazit plný text záznamu
5
Akademický článek
A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner
Autor: Floriane Auderset, Elodie Belnoue, Beatris Mastelic-Gavillet, Paul-Henri Lambert, Claire-Anne Siegrist
Publikováno v: Frontiers in Immunology, Vol 11 (2020)
Novel adjuvants, such as Toll-like receptors (TLRs) agonists, are needed for the development of new formulations able to circumvent limitations of current vaccines. Among TLRs, TLR7/8 agonists represent promising candidates, as they are well describe
Externí odkaz: https://doaj.org/article/7af591375e2849ba84d744b2876ec670
Zobrazit plný text záznamu
6
Akademický článek
In-vivo gp100-specific Cytotoxic CD8+ T Cell Killing Assay
Autor: Mahdia Benkhoucha, Nicolas Molnarfi, Elodie Belnoue, Madiha Derouazi, Patrice Lalive
Publikováno v: Bio-Protocol, Vol 8, Iss 22 (2018)
Cytotoxic CD8+ T lymphocytes (CTLs) represent a crucial component of the adaptive immune system and play a prominent role in the anti-tumor immune responses of both mice and humans. Cytotoxic CD8+ T cells are responsible for the lysis of cells expres
Externí odkaz: https://doaj.org/article/449ca97ec51846e98d88bb7f1945220a
Zobrazit plný text záznamu
7
Akademický článek
Functional limitations of plasmacytoid dendritic cells limit type I interferon, T cell responses and virus control in early life.
Autor: Elodie Belnoue, Paola Fontannaz, Anne-Françoise Rochat, Chantal Tougne, Andreas Bergthaler, Paul-Henri Lambert, Daniel D Pinschewer, Claire-Anne Siegrist
Publikováno v: PLoS ONE, Vol 8, Iss 12, p e85302 (2013)
Infant mortality from viral infection remains a major global health concern: viruses causing acute infections in immunologically mature hosts often follow a more severe course in early life, with prolonged or persistent viral replication. Similarly,
Externí odkaz: https://doaj.org/article/7e2c1e8b65d647c3abe52c2d8c51b1c4
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje